Posts Tagged: "Horizon Pharma"

Horizon Pharma patents covering Vimovo arthritis pain relief treatment have validity upheld at district court and PTAB

Irish biopharmaceutical firm Horizon Pharma announced that two of its patents covering Vimovo, a pain relief treatment for arthritis patients, had their validity upheld in a patent infringement case filed in the District of New Jersey (D.N.J.). The decision allows Horizon Pharma to move forward with its argument that at least one of the two upheld patents would be infringed by generic versions of Vimovo being developed by Indian drugmakers Lupin Limited and Dr. Reddy’s Laboratories as well as American generic drugmaker Mylan.

Horizon Pharma sues Actavis, Lupin for Paragraph IV certifications on generic Pennsaid

Horizon Pharma filed an action for patent infringement against Actavis and Lupin Pharmaceuticals in response to the filing of Abbreviated New Drug Applications (ANDAs) by both defendants for a generic version of Pennsaid, a topical nonsteroidal anti-inflammatory drug (NSAID) marketed in the U.S. by Horizon. Both cases were filed in the U.S. District Court for the District of New Jersey.